People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotech, Pharma, Hospitals and Physicians, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Octave Bioscience Inc | — | Biotech | Series B | $105.8M | $169.5M | 2020 |
| Oncology Analytics, Inc. | — | Pharma | Series B | $53.5M | $850.1M | 2016 |
| AbleTo, Inc. | — | Hospitals and Physicians | Series B | $52.6M | $175.1M | 2014 |
| Mental Health Data Services, Inc. | — | Healthtech | Series B | $25.0M | $60.5M | 2020 |
| Humata Health, Inc. | — | Healthtech | Series B | $25.0M | $174.5M | 2024 |
| BehaveCare Inc. | — | Other Health Care | Series A | $24.3M | $137.1M | 2017 |
Thomas Hawes at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Hawes on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brook Byers | 1 | 13 |
| Liam Donohue | 1 | 12 |
| Enrico Picozza | 1 | 7 |
| Andrea Jackson | 1 | 6 |
| Marc Lippman | 1 | 5 |
| William Bennett | 1 | 5 |
| Word D. Peake | 1 | 5 |
| Eric Heil | 1 | 5 |
| Arnold Silverman | 1 | 5 |
| Yumin Choi | 1 | 4 |
| William Hagstrom | 1 | 4 |
| Victor Kats | 1 | 4 |
| George Scangos | 1 | 4 |
| Mark Weeks | 1 | 4 |
| Michael Pellini | 1 | 4 |
| Eric Meier | 1 | 3 |
| Michael Laskoff | 1 | 3 |
| Robert Rebak | 1 | 3 |
| Robert Walton | 1 | 3 |
| Jeffrey T. Webber | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.